Joshua Armenia

6PUBLICATIONS
80CO-AUTHORS
Molecular targetsPredictive and prognostic markersEvolution of developmental systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 01, 2026
Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study.

|Mar 27, 2023
Drug-gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition.

Kunzah Jamal, Alessandro Galbiati, Joshua Armenia

|Aug 03, 2022
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance.

Violeta Serra, Anderson T Wang, Marta Castroviejo-Bermejo

|Jun 02, 2019
Publisher Correction: The long tail of oncogenic drivers in prostate cancer.

Joshua Armenia, Stephanie A M Wankowicz, David Liu

|Jul 18, 2018
Genome doubling shapes the evolution and prognosis of advanced cancers.

Craig M Bielski, Ahmet Zehir, Alexander V Penson

|Apr 04, 2018
The long tail of oncogenic drivers in prostate cancer.

Joshua Armenia, Stephanie A M Wankowicz, David Liu

Pageof 1

Frequent Collaborators

3 joint publications

Walid K Chatila

3 joint publications

Barry S Taylor

2 joint publications

Ed Reznik

2 joint publications

Susana Miranda